
Oncotelic Therapeutics Highlighted in BioMedWire Editorial on Biotech Valuation Shift as Drug Pipelines Become Measurable Financial Assets
Oncotelic Therapeutics is featured in a BioMedWire editorial that explores how advancing drug pipelines are reshaping biotech valuations under evolving accounting frameworks, highlighting the company's AI-driven oncology pipeline and strategic holdings as examples of innovation translating into enterprise value.
Read full story

























